Qin-fen Chen

Wenzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications

Burden and Regional Disparities of MASH-Related Liver Cancer in the Asia-Pacific Region From 1990 to 2023.

Burden and Regional Disparities of MASH-Related Liver Cancer in the Asia-Pacific Region From 1990 to 2023.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 30, 2026

Trajectory of liver-related events following incident cardiovascular disease in MASLD: A 15-year population-based cohort study.

Trajectory of liver-related events following incident cardiovascular disease in MASLD: A 15-year population-based cohort study.

Journal: Metabolism: clinical and experimental
Published: March 10, 2026

Burden of metabolic dysfunction-associated steatotic liver disease in the Asia-Pacific region from 1990 to 2023.

Burden of metabolic dysfunction-associated steatotic liver disease in the Asia-Pacific region from 1990 to 2023.

Journal: eGastroenterology
Published: January 14, 2026

Ferroptosis in MASLD: From molecular mechanisms to therapeutic opportunities.

Ferroptosis in MASLD: From molecular mechanisms to therapeutic opportunities.

Journal: Med (New York, N.Y.)
Published: November 10, 2025

Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities.

Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities.

Journal: Gut
Published: October 31, 2025

Progression of Liver Fibrosis and Liver-Related Event Risk in MASLD at High Cardiovascular Risk.

Progression of Liver Fibrosis and Liver-Related Event Risk in MASLD at High Cardiovascular Risk.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 28, 2025

Progression of Liver Fibrosis and Liver-related Event Risk in Metabolic Dysfunction-associated Steatotic Liver Disease at High Cardiovascular Risk.

Progression of Liver Fibrosis and Liver-related Event Risk in Metabolic Dysfunction-associated Steatotic Liver Disease at High Cardiovascular Risk.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 28, 2025

Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region.

Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region.

Journal: Metabolism: clinical and experimental
Published: October 28, 2025

Cardiovascular-kidney-metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD.

Cardiovascular-kidney-metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD.

Journal: Hepatology (Baltimore, Md.)
Published: September 12, 2025

Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLD.

Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLD.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 11, 2025

MASLD as a systemic metabolic disease: expanding the scope of cardiovascular-kidney-metabolic (CKM) syndrome.

MASLD as a systemic metabolic disease: expanding the scope of cardiovascular-kidney-metabolic (CKM) syndrome.

Journal: Science China. Life sciences
Published: August 27, 2025

Validation of a data-driven clustering model for MASLD: Evidence from three large-scale Asian cohorts.

Validation of a data-driven clustering model for MASLD: Evidence from three large-scale Asian cohorts.

Journal: JHEP reports : innovation in hepatology
Published: June 26, 2025
Showing 1-12 of 49

Last Updated: 09/26/2026